Cases
Rowan Companies plc (RDC)
Merger
Overview
Overview
- Date:
- 10/8/2018
- Company Name:
- Rowan Companies plc
- Stock Symbol:
- RDC
- Company Name - Buyer:
- Ensco plc
- Status:
- Closed/Complete
- Merger Announcement Date:
- 10/8/2018
NEW YORK, October 8, 2018 – Bragar Eagel & Squire, P.C. is investigating potential claims against Rowan Companies plc (NASDAQ: RDC) on behalf of stockholders concerning the proposed acquisition of the company by Ensco plc.
Pursuant to the proposed transaction, announced on October 8, 2018, Rowan stockholders will receive 2.215 shares of Ensco for each share of Rowan common stock owned. The investigation focuses on whether Rowan and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own Rowan shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 308-1869, or by filling out the contact form below. There is no cost or obligation to you.
Pursuant to the proposed transaction, announced on October 8, 2018, Rowan stockholders will receive 2.215 shares of Ensco for each share of Rowan common stock owned. The investigation focuses on whether Rowan and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own Rowan shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 308-1869, or by filling out the contact form below. There is no cost or obligation to you.